文献速递脊柱关节炎其他结缔组织病

乌司奴单抗妊娠期安全性:综合综述

Ustekinumab Safety in Pregnancy: A Comprehensive Review.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-11-16

本综述评估了动物研究、病例报告、病例系列、观察性研究和临床实践指南中关于乌司奴单抗妊娠期安全性的证据,发现迄今研究未识别出暴露于乌司奴单抗的妊娠女性不良妊娠结局风险增加,但暴露妊娠数少且可能存在偏倚,临床指南对是否继续或停用乌司奴单抗存在分歧。

要点

  • 迄今研究未发现妊娠期暴露乌司奴单抗者不良妊娠结局风险增加。
  • 暴露妊娠数量少且可能存在偏倚,证据有限。
  • 临床指南对妊娠期继续或停用乌司奴单抗存在分歧。

核心结论

  • 迄今研究未识别出妊娠期暴露于乌司奴单抗的女性不良妊娠结局风险增加,但暴露妊娠数少且可能存在一些偏倚。
  • 临床指南对是否推荐继续或停用乌司奴单抗存在分歧,凸显数据匮乏和需要更多研究。

研究设计与样本

  • 综合综述,批判性评估动物研究、人类病例报告、病例系列、观察性研究和临床实践指南中关于乌司奴单抗妊娠期安全性的现有证据。

主要发现

  • 迄今研究未识别出妊娠期暴露于乌司奴单抗的女性不良妊娠结局风险增加。
  • 暴露妊娠数少且可能存在一些偏倚。
  • 临床指南对妊娠期继续或停用乌司奴单抗存在分歧。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 暴露妊娠数少且可能存在一些偏倚。
  • 临床指南存在分歧,凸显数据匮乏和需要更多研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic inflammatory conditions, including inflammatory bowel diseases (IBD), psoriasis, and psoriatic arthritis, are prevalent among women of reproductive age; patients with active disease during pregnancy may be at an increased risk of adverse birth outcomes. For this reason, physicians are focused on approaches to controlling disease activity prior to and during pregnancy. The safety profile of many therapies used for these conditions has been relatively well established, though evidence on newer therapies is lacking. Ustekinumab is a relatively new interleukin-12/23 inhibitor approved for IBD, psoriasis, and psoriatic arthritis, whose safety in pregnancy is not yet fully understood. In this comprehensive review, we critically assess the available evidence on ustekinumab in pregnancy across animal studies and human case reports, case series, observational studies, and clinical practice guidelines. We show that, to date, studies have not identified an excess risk of adverse pregnancy outcomes among women exposed to ustekinumab in pregnancy, with few exposed pregnancies and potential for some bias. Clinical guidelines are conflicted regarding whether they recommend continuing or discontinuing ustekinumab, highlighting the paucity of data and need for more research on this issue.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Gorodensky JH, Bernatsky S, Afif W, et al. Ustekinumab Safety in Pregnancy: A Comprehensive Review. Arthritis Care Res (Hoboken). 2022. PMID: 34748293. doi:10.1002/acr.24813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。